QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.104.067330v1 310/3/1003    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kaminskas, L. M. Articles by Burcham, P. C. Search for Related Content PubMed PubMed Citation Articles by Kaminskas, L. M. Articles by Burcham, P. C. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB ACROLEIN ALLYL ALCOHOL HYDRALAZINE HYDROCHLORIDE

TOXICOLOGY

Strong Protein Adduct Trapping Accompanies Abolition of Acrolein-Mediated Hepatotoxicity by Hydralazine in Mice

Molecular Toxicology Research Group, Departments of Clinical and Experimental Pharmacology (P.C.B., L.M.K.) and Chemistry (S.M.P., L.M.K.), the University of Adelaide, Adelaide, South Australia, Australia

Acrolein is a highly reactive ,-unsaturated aldehyde that readily alkylates nucleophilic centers in cell macromolecules. Typically, such reactions proceed via Michael addition chemistry, forming adducts that retain an electrophilic carbonyl group. Since these species participate in secondary deleterious reactions, we hypothesize that inactivation of carbonyl adducts may attenuate acrolein toxicity. Indeed, we recently established that the nucleophilic antihypertensive drug hydralazine readily "traps" acrolein adducts in cell proteins and strongly suppresses acrolein-mediated toxicity in isolated hepatocytes. This work sought to determine whether hydralazine prevents the in vivo hepatotoxicity of the acrolein precursor allyl alcohol in whole mice and whether adduct trapping accompanies any such hepatoprotection. Mice received allyl alcohol alone or in conjunction with several doses of hydralazine. Four hours later, mice were sacrificed to allow for the determination of liver enzymes in plasma as markers of hepatic injury, whereas livers were assessed for glutathione and hydralazine-stabilized protein adducts. Hydralazine afforded strong, dose-dependent protection against the increases in plasma marker enzymes but not the hepatic glutathione depletion produced by allyl alcohol. Western blotting revealed intense, dose-dependent adduct trapping by hydralazine in numerous liver proteins over a broad 26- to 200-kDA mass range. In keeping with these findings, immunohistochemical analysis of liver slices indicated diffuse, extranuclear adduct trapping by hydralazine that was uniformly distributed across the liver lobule, with partial localization in parenchymal cell membranes. These findings concur with our hypothesis that hydralazine readily inactivates reactive carbonyl-retaining protein adducts formed by acrolein, thereby preventing secondary reactions that trigger cellular death.

Address correspondence to: Dr. Philip C. Burcham, Molecular Toxicology Research Group, Department of Clinical and Experimental Pharmacology, The University of Adelaide, Adelaide, SA 5005, Australia. E-mail: philip.burcham{at}adelaide.edu.au

This article has been cited by other articles:

				O Faroon, N Roney, J Taylor, A Ashizawa, M. Lumpkin, and D. Plewak Acrolein health effects Toxicology and Industrial Health, August 1, 2008; 24(7): 447 - 490. [Abstract] [PDF]

				A. Tanel and D. A. Averill-Bates Inhibition of Acrolein-Induced Apoptosis by the Antioxidant N-Acetylcysteine J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 73 - 83. [Abstract] [Full Text] [PDF]

				P. C. Burcham and S. M. Pyke Hydralazine Inhibits Rapid Acrolein-Induced Protein Oligomerization: Role of Aldehyde Scavenging and Adduct Trapping in Cross-Link Blocking and Cytoprotection Mol. Pharmacol., March 1, 2006; 69(3): 1056 - 1065. [Abstract] [Full Text] [PDF]

				Z. Yan, H. M. Zhong, N. Maher, R. Torres, G. C. Leo, G. W. Caldwell, and N. Huebert BIOACTIVATION OF 4-METHYLPHENOL (p-CRESOL) VIA CYTOCHROME P450-MEDIATED AROMATIC OXIDATION IN HUMAN LIVER MICROSOMES Drug Metab. Dispos., December 1, 2005; 33(12): 1867 - 1876. [Abstract] [Full Text] [PDF]